STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say
STAT [Unofficial]
April 7, 2026
Resarchers say Merck should 'urgently begin licensing generic production to its HIV prevention pill.
Discussion in the ATmosphere